* Avanos Medical Inc AVNS.N reported quarterly adjusted
earnings
of 42 cents per share for the quarter ended in September,
higher than the same quarter last year, when the company
reported EPS of 38 cents. The mean expectation of
three analysts for the quarter was for earnings of 28 cents per
share. Wall Street expected results to range from 26 cents to 30
cents per share.
* Revenue rose 0.1% to $202.40 million from a year ago;
analysts
expected $169.60 million.
* The company reported a quarterly loss of $3.7 million.
* Avanos Medical Inc shares had fallen by 9.2% this
quarter and
lost 32.2% so far this year.
FORECAST CHANGES
* The mean earnings estimate of analysts had fallen by
about 33%
in the last three months.
* In the last 30 days, one analyst negatively revised an
earnings
estimate
RECOMMENDATIONS
* The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell."
* The average consensus recommendation for the medical
equipment,
supplies & distribution peer group is also "hold"
Wall Street's median 12-month price target for Avanos Medical
Inc is $28.00
This summary was machine generated from LSEG data November 1 at
01:32 p.m. UTC. All figures in US dollars unless otherwise
stated. QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Sep. 30 2023 0.28 0.42 Beat
Jun. 30 2023 0.30 0.37 Beat
Mar. 31 2023 0.27 0.27 Met
Dec. 31 2022 0.49 0.60 Beat